Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation

被引:0
|
作者
Fernandez-Munoz, Hermogenes [1 ,2 ]
Plaza, Eva M. [1 ]
Miguel Rivera-Caravaca, Jose [1 ]
Jose Candela, Maria [1 ]
Romera, Marta [1 ,3 ]
De Arriba, Felipe [1 ]
Lozano, Maria L. [1 ]
Vicente, Vicente [1 ]
Heras, Inmaculada [1 ]
Castilla-Llorente, Cristina [1 ,4 ]
Rivera, Jose [1 ]
机构
[1] Univ Murcia, Hosp Univ Morales Meseguer, Ctr Reg Hemodonac, Serv Hematol & Oncol Med,CIBERER,IMIB Arrixaca, Murcia, Spain
[2] Hosp Univ Rafael Mendez, Serv Hematol & Hemoterapia, Lorca, Spain
[3] Hosp Univ Santa Lucia, Serv Hematol & Hemoterapia, Cartagena, Spain
[4] Inst Gustave Roussy, Serv Hematol, Villejuif, France
关键词
Buffy-coat; platelet-rich plasma; correct count increment; platelet transfusion; allogeneic hematopoietic cell transplant; whole blood derived platelets; platelet concentrates; bleeding outcomes; WHOLE-BLOOD; APHERESIS; INCREMENTS; REFRACTORINESS; ENGRAFTMENT; LEUKEMIA; EFFICACY; STORAGE; PLASMA; IMPACT;
D O I
10.1080/10245332.2018.1455434
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Whole blood-derived platelet concentrates can be obtained by the platelet-rich plasma (PRP-PCs) or the buffy-coat (BC-PCs) method. Few studies have shown that BC-PCs display lower in vitro platelet activation, but scarce information exists regarding transfusion efficacy. We have performed a retrospective study assessing platelet transfusion in patients undergoing allogeneic hematopoietic cell transplantation (AHCT) in our clinic, before and after the implementation of BC-PCs. Methods: We reviewed clinical records corresponding to 70 PRP-PCs and 86 BC-PCs prophylactic transfusions, which were performed to 55 AHCT patients. Transfusion efficacy was assessed by the 24-h post-transfusion corrected count increment (24-h CCI) and bleeding events. Clinical factors affecting transfusion outcome were also investigated. Results: Clinical characteristics and the total number of platelet transfusions were similar among groups. Mean donor exposure was 5.8 and 5.0 in each single PRP-PCs and BC-PCs transfusion, respectively (p < 0.01). The 24-h CCI was significantly higher in patients transfused with BC-PCs than in those receiving PRP-PCs (8.3[2.7-13.4] vs. 4.7[1.3-8.1]; p < 0.01). Independent predictors of poor platelet transfusion response included diagnosis other than acute leukemia (HR 8.30; 95% CI 1.96-35.22; p = 0.004), splenomegaly (HR 8.75; 95% CI 2.77-27.60; p < 0.001), graft versus host disease prophylaxis different from cyclosporine A and methotrexate (HR 3.96; 95% CI 1.55-10.14; p = 0.004) and PRP-PCs transfusion (HR 4.54; 95% CI 1.72-12.01; p = 0.002). There were no differences between both groups regarding the bleeding events. Conclusion: In the AHCT setting, we hypothesize that BC-PCs transfusion, when compared to PRP-PCs, results in higher CCI and reduced donor exposure, but provides no significant benefit regarding bleeding outcome.
引用
收藏
页码:712 / 718
页数:7
相关论文
共 48 条
  • [41] Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
    Harada, Kaito
    Konuma, Takaaki
    Machida, Shinichiro
    Mori, Jinichi
    Aoki, Jun
    Uchida, Naoyuki
    Ohashi, Kazuteru
    Fukuda, Takahiro
    Tanaka, Masatsugu
    Ikegame, Kazuhiro
    Ozawa, Yukiyasu
    Iwato, Koji
    Eto, Tetsuya
    Onizuka, Makoto
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Yano, Shingo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (09) : 1730 - 1743
  • [42] WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell-depleted hematopoietic stem cell transplantation and donor lymphocyte infusions
    Tyler, Eleanor M.
    Jungbluth, Achim A.
    O'Reilly, Richard J.
    Koehne, Guenther
    BLOOD, 2013, 121 (02) : 308 - 317
  • [43] Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Jeon, Young-Woo
    Yoon, Seugyun
    Min, Gi June
    Park, Sung-Soo
    Park, Silvia
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo Jin
    Kim, Hee-Je
    Lee, Seok
    Min, Chang-Ki
    Lee, Jong Wook
    Cho, Seok-Goo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (06) : 345 - +
  • [44] Comparative study on allogeneic with autologous hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in the era of TKIs: a systematic review and meta-analysis
    Wei, Haichen
    Kuang, Pu
    Liu, Ting
    ANNALS OF HEMATOLOGY, 2020, 99 (11) : 2619 - 2628
  • [45] Comparing the outcomes between TMLI and non-TMLI conditioning regimens for adult high-risk acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: a single-center experience
    Zhao, Xiaoyan
    Lu, Xuan
    Tang, Liang
    Yan, Han
    Chen, Wenlan
    Shi, Wei
    Zhong, Zhaodong
    You, Yong
    Xia, Linghui
    Hu, Yu
    Wang, Huafang
    LEUKEMIA & LYMPHOMA, 2020, 61 (12) : 2859 - 2867
  • [46] Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual disease
    Zheng, Jing
    Zhou, Yuping
    Zhao, Yanmin
    Luo, Yi
    Yu, Jian
    Lai, Xiaoyu
    Wang, Jinuo
    Ye, Yishan
    Liu, Lizhen
    Fu, Huarui
    Yang, Luxin
    Wu, Yibo
    Sun, Jie
    Zheng, Weiyan
    He, Jingsong
    Zhao, Yi
    Wu, Wenjun
    Cai, Zhen
    Wei, Guoqing
    Huang, He
    Li, Weiming
    Shi, Jimin
    ANNALS OF HEMATOLOGY, 2025, : 1867 - 1876
  • [47] Graft-versus-Host Disease Prophylaxis with PostTransplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)
    Orti, Guillermo
    Gras, Luuk
    Koster, Linda
    Kulagin, Aleksander
    Byrne, Jenny
    Apperley, Jane F.
    Halaburda, Kazimierz
    Blau, Igor Wolfgang
    Clark, Andrew
    Kroeger, Nicolaus
    Griskevicius, Laimonas
    Carlson, Kristina
    Collin, Matthew
    Bloor, Adrian
    Raiola, Anna Maria
    Blaise, Didier
    Aljurf, Mahmoud
    Lopez-Corral, Lucia
    Sakellari, Ioanna
    Beguin, Yves
    Wrobel, Tomasz
    de Rosa, Luca
    de Lavallade, Hughes
    Hayden, Patrick J.
    McLornan, Donal
    Chalandon, Yves
    Yakoub-Agha, Ibrahim
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 93.e1 - 93.e12
  • [48] Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification
    Kim, Tong-Yoon
    Park, Silvia
    Kwag, Daehun
    Lee, Jong-Hyuk
    Lee, Joonyeop
    Min, Gi-June
    Park, Sung-Soo
    Jeon, Young-Woo
    Shin, Seung-Hawn
    Yahng, Seung-Ah
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong-Wook
    Kim, Hee-Je
    CANCERS, 2022, 14 (13)